New medication that spur weight loss and handle diabetes have been getting the public—along with the pharmaceutical field—by storm. The most up-to-date entrant, Zepbound, lately joined Ozempic, Wegovy, Victoza and Other people in a very developing course of medication termed GLP-one receptor agonists.Disclaimer: Health care News Nowadays has pr